Survival rates of those diagnosed with sarcoma are low and treatments for the disease haven't improved in almost 40 years.
But change is coming.
Doctor David Thomas, from the Garvan Institute of Medical Research in Sydney, is part of an international team that has found a new diagnostic tool.
It targets patients with a specific genetic indicator.